Market News AIOpen the app

NTLA stock news · Intellia Therapeutics

Stories about Intellia Therapeutics (NTLA) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for NTLA

Follow Intellia Therapeutics (NTLA) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for NTLA
Free on the App Store and Google Play, or on the web.
  1. Oct 5, 2026, 6:34 AM ET · Results

    Intellia Therapeutics shares what happened during their earnings call for the second quarter of 2026.

    Good for NTLA

    Intellia reported strong results from its HAE trial and cash expected to last into 2028. These updates support a brighter outlook, though FDA approval is not certain.

  2. Sep 21, 2026, 1:42 PM ET · Market

    Big investors are making moves in 10 health care stocks today.

    Bad for NTLA

    Intellia saw a call option trade flagged bearish; 283 contracts were traded at the $15 strike expiring Jan 21, 2028.